Guru Ownership Trend
Guru Analysis for United Therapeutics Corporation (UTHR)
United Therapeutics Corporation (UTHR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.64 B.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bearish. This is evidenced by a $343.16 M net outflow during the quarter.
Recent activity highlights Jeremy Grantham who increased their stake by 458.6%. Conversely, Cliff Asness reduced exposure by 35.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for United Therapeutics Corporation (UTHR)
Major holders include Renaissance Technologies (RenTech) ($1.06 B), Cliff Asness ($486.42 M), Steven Cohen ($88.53 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 3 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $343.16 M, with 5 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 1 fully exited UTHR. The total reported sell value was $375.88 M.
Yes, 1 managers opened new positions in UTHR, and 4 increased their existing holdings. The total reported buy value was $32.72 M.
